Mangan Patricia A, Gleason Charise L, Miceli Teresa
Abramson Cancer Center, University of Pennsylvania, Philadelphia.
Clin J Oncol Nurs. 2013 Dec;17 Suppl:43-7. doi: 10.1188/13.CJON.43-47.
When caring for patients with multiple myeloma, questions often arise about the role and timing of autologous hematopoietic stem cell transplantation. As a complement to the other articles in this supplement, as well as to ensure that readers are provided with the insight needed to feel comfortable speaking to patients and other practitioners about this topic, the authors address eight frequently asked questions about common decision points in the process of autologous hematopoietic stem cell transplantation as a treatment for patients with multiple myeloma.
在护理多发性骨髓瘤患者时，关于自体造血干细胞移植的作用和时机常常会出现一些问题。作为本增刊中其他文章的补充，同时为确保读者具备必要的见解，以便能够自如地与患者及其他从业者谈论这一话题，作者针对自体造血干细胞移植治疗多发性骨髓瘤过程中常见决策点的八个常见问题进行了解答。
